Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-01

Clinical Trial Update: Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease [Phase 4]

View source ↗

Summary

This Phase 4 study evaluated how much dolutegravir is removed by hemodialysis in HIV-infected patients with end-stage renal disease to inform dosing in this pop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV | Phase 4 | Status: COMPLETED